RSV Vaccines Are Finally Here after Decades of False Starts
Posted on AllSides May 4th, 2023
From The Left
Editor’s Note (5/3/23): The U.S. Food and Drug Administration has approved GSK’s respiratory syncytial virus (RSV) vaccine for adults age 60 and older—the first approved vaccine for this disease. The road to its development was long and bumpy but ultimately successful, as detailed in this story published on March 20. Megan Smith was especially conscious of the threat COVID posed to her six-week-old daughter in October 2021. The now 36-year-old from Buffalo, N.Y., was “doing everything we could to protect her,” Smith says. Ultimately, though, it wasn’t COVID that sent...
Some content from this outlet may be limited or behind a paywall.